Preventing early disease progression in follicular lymphoma

Preventing early disease progression in follicular lymphoma

VJHemOnc

1 year
51 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
While treatment for follicular lymphoma (FL) has improved in recent years, allowing most patients to have good outcomes, there remains a small subset of patients who experience disease progression within 24 months of chemoimmunotherapy. In this video, recorded at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden, John Seymour, MBBS, FRACP, PhD, of the Peter MacCallum Cancer Center, Victoria, Australia, discusses the importance of identifying and treating these high risk patients. He gives an overview of existing prognostic indices, including FLIPI, FLIPI2 and the PRIMA prognostic index, as well as newer, more accurate methods that incorporate genetic screening, such as the m7-FLIPI and the POD24 predictive index. Finally, Dr Seymour touches upon the results from the GALLIUM study (NCT01332968), which show that early disease progression can be reduced with obinutuzumab.
Up Next Autoplay
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,010 Views
imedex 5 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
388 Views
imedex 5 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
325 Views
imedex 5 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
241 Views
imedex 5 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
227 Views
imedex 5 months
ASH 2016 Page 5 Update on CAR-T Cell Therapy in Lymphoma
ASH 2016 Page 5 Update on CAR-T Cell Therapy in Lymphoma
Category: Lymphoma
409 Views
cancergrace 5 months
ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
ASH 2016 Page 4 Update on Antibody Therapies in Indolent Non-Hodgkin Lymphoma
Category: Lymphoma
187 Views
cancergrace 5 months
ASH 2016 Page 8 Leonard New Data for Mantel Cell and T-Cell Lymphoma Patients
ASH 2016 Page 8 Leonard New Data for Mantel Cell and T-Cell Lymphoma Patients
Category: Lymphoma
69 Views
cancergrace 5 months
ASH 2016  Page 7 Leonard Follicular Lymphoma Treatment Update
ASH 2016 Page 7 Leonard Follicular Lymphoma Treatment Update
Category: Lymphoma
86 Views
cancergrace 5 months
ASH 2016 Page 6 Leonard Update on Diffuse Large B Cell Lymphoma Treatments
ASH 2016 Page 6 Leonard Update on Diffuse Large B Cell Lymphoma Treatments
Category: Lymphoma
21 Views
cancergrace 5 months